| Oct 5, 2026 | Matthew Bowen | PRINCIPAL ACCOUNTING OFFICER | SELL | 13.000 | $10.56 | $137 |
| Jul 16, 2026 | Markus Warmuth | PRESIDENT & CEO | SELL | 9.500K | $23.18 | $220K |
| Jul 15, 2026 | Jennifer Champoux | CHIEF OPERATING OFFICER | SELL-OPTIONS | — | $13.68 | $84K |
| Jul 6, 2026 | Sharon Townson | CHIEF SCIENTIFIC OFFICER | SELL-OPTIONS | — | $14.72 | $103K |
| Jun 30, 2026 | Filip Janku | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $18.95 | $60K |
| Jun 29, 2026 | Filip Janku | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $15.25 | $92K |
| Jun 29, 2026 | Anthony Manning | — | SELL-OPTIONS | — | $13.63 | $190K |
| Jun 23, 2026 | Filip Janku | CHIEF MEDICAL OFFICER | SELL | 5.845K | $14.32 | $610K |
| Jun 23, 2026 | Jennifer Champoux | CHIEF OPERATING OFFICER | SELL-OPTIONS | — | $11.99 | $35K |
| Jun 23, 2026 | Sharon Townson | CHIEF SCIENTIFIC OFFICER | SELL-OPTIONS | — | $13.07 | $42K |
| Jun 17, 2026 | Jennifer Champoux | CHIEF OPERATING OFFICER | SELL-OPTIONS | — | $11.49 | $33K |
| Jun 17, 2026 | Sharon Townson | CHIEF SCIENTIFIC OFFICER | SELL-OPTIONS | — | $12.57 | $39K |
| Jun 1, 2026 | Markus Warmuth | PRESIDENT & CEO | SELL | 5.466K | $19.44 | $106K |
| May 29, 2026 | Sharon Townson | CHIEF SCIENTIFIC OFFICER | SELL-OPTIONS | — | $13.01 | $82K |
| May 27, 2026 | Jennifer Champoux | CHIEF OPERATING OFFICER | SELL-OPTIONS | — | $11.99 | $35K |
| May 22, 2026 | Jennifer Champoux | CHIEF OPERATING OFFICER | SELL-OPTIONS | — | $11.49 | $33K |
| May 21, 2026 | Anthony Manning | — | SELL-OPTIONS | — | $11.09 | $139K |
| May 1, 2026 | Markus Warmuth | PRESIDENT & CEO | SELL | 5.467K | $18.92 | $103K |
